Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report)’s stock price rose 21.4% during trading on Monday . The stock traded as high as C$0.21 and last traded at C$0.17. Approximately 1,548,155 shares changed hands during trading, an increase of 298% from the average daily volume of 388,528 shares. The stock had previously closed at C$0.14.
Voyageur Pharmaceuticals Price Performance
The company has a debt-to-equity ratio of 3.21, a current ratio of 0.17 and a quick ratio of 0.84. The stock has a 50 day simple moving average of C$0.08 and a two-hundred day simple moving average of C$0.06. The company has a market cap of C$18.83 million, a price-to-earnings ratio of -13.50 and a beta of 0.32.
About Voyageur Pharmaceuticals
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Read More
- Five stocks we like better than Voyageur Pharmaceuticals
- How to Use the MarketBeat Stock Screener
- Rigetti Computing, Inc.: Buy, Sell, or Hold for 2025
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Delta Can Fly to New Highs in 2025; Here’s Why
- What Are the U.K. Market Holidays? How to Invest and Trade
- Snowflake Stock: Bullish Upgrades Demand Investors’ Attention
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
